Advertisement
Improvements enable targeting of brain tumors with single-session, fractionated or neoadjuvant approaches
We now have an expanded toolbox to extend survival and lessen treatment toxicity
Insights on leveraging collaboration and advocacy to develop and conduct needed trials
Findings implicate hydrogen sulfide dysfunction, point to potential treatment strategies
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Pairing low-frequency ultrasound with microbubble resonators to penetrate the blood-brain barrier
Single-cell RNA sequencing, the microbiome and more offer insight into complex brain tumors
Minimally invasive procedure allows surgeons to remove orbital and intracranial tumors without the need for a craniotomy
Positioning the technology in the current therapeutic landscape
Advertisement
Advertisement